Instil Bio, Inc. (TIL)
Total Valuation
Instil Bio has a market cap or net worth of $52.72 million. The enterprise value is -$62.84 million.
| Market Cap | 52.72M |
| Enterprise Value | -62.84M |
Important Dates
The next estimated earnings date is Monday, November 13, 2023, before market open.
| Earnings Date | Nov 13, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
Instil Bio has 130.08 million shares outstanding. The number of shares has increased by 0.55% in one year.
| Shares Outstanding | 130.08M |
| Shares Change (YoY) | +0.55% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.84% |
| Owned by Institutions (%) | 71.53% |
| Float | 68.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.18 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.00, with a Debt / Equity ratio of 0.29.
| Current Ratio | 12.00 |
| Quick Ratio | n/a |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -66.23 |
Financial Efficiency
Return on equity (ROE) is -53.80% and return on invested capital (ROIC) is -38.90%.
| Return on Equity (ROE) | -53.80% |
| Return on Assets (ROA) | -40.20% |
| Return on Capital (ROIC) | -38.90% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$967,698 |
| Employee Count | 192 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -976,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.37% in the last 52 weeks. The beta is 1.26, so Instil Bio's price volatility has been higher than the market average.
| Beta (1Y) | 1.26 |
| 52-Week Price Change | -91.37% |
| 50-Day Moving Average | 0.49 |
| 200-Day Moving Average | 0.62 |
| Relative Strength Index (RSI) | 40.20 |
| Average Volume (30 Days) | 365,139 |
Short Selling Information
The latest short interest is 758,401, so 0.58% of the outstanding shares have been sold short.
| Short Interest | 758,401 |
| Short Previous Month | 809,620 |
| Short % of Shares Out | 0.58% |
| Short % of Float | 1.11% |
| Short Ratio (days to cover) | 3.60 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -192.88M |
| Pretax Income | -186.77M |
| Net Income | -185.80M |
| EBITDA | -176.14M |
| EBIT | -184.00M |
| Earnings Per Share (EPS) | -$1.42 |
Balance Sheet
The company has $201.70 million in cash and $85.21 million in debt, giving a net cash position of $116.49 million or $0.90 per share.
| Cash & Cash Equivalents | 201.70M |
| Total Debt | 85.21M |
| Net Cash | 116.49M |
| Net Cash Per Share | $0.90 |
| Equity / Book Value | 296.52M |
| Book Value Per Share | 2.28 |
| Working Capital | 202.21M |
Cash Flow
In the last 12 months, operating cash flow was -$132.08 million and capital expenditures -$53.66 million, giving a free cash flow of -$185.73 million.
| Operating Cash Flow | -132.08M |
| Capital Expenditures | -53.66M |
| Free Cash Flow | -185.73M |
| FCF Per Share | -$1.43 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Instil Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -346.35% |
| FCF Yield | -346.23% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.55% |
| Shareholder Yield | -0.55% |
Analyst Forecast
The average price target for Instil Bio is $6.00, which is 1,380.39% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.00 |
| Price Target Difference | 1,380.39% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |